Drugs / panHer
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00095537 | Mar 2004 → May 2006 | cancer, metastatic neoplasm | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | panHer | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00095537 ↗ |
| Route | Oral | “Tablets, Oral” NCT00095537 ↗ |
| Target | EGFR | “a drug that is directed against EGFR and HER2 proteins” NCT00095537 ↗ |